Sustainable finance initiatives are designed to mobilise private sector investment to support the transition towards a sustainable global economy. These initiatives are expanding to integrate broader environmental issues. So, we asked a panel of experts, what are the opportunities and challenges for integrating pharmaceutical pollution into sustainable finance initiatives?

Welcome to our Consortium Spotlight, where we shine a light on our diverse community of experts dedicated to reducing the environmental impact of medicines in UK healthcare. This month we feature Dr Hannah Blitzer Senior Policy Officer at Wildlife and Countryside Link.

Welcome to our Consortium Spotlight, where we shine a light on our diverse community of experts dedicated to reducing the environmental impact of medicines in UK healthcare. First, we have the pleasure of featuring Professor Heather Brown, a distinguished health economist and Professor of Health Inequalities.

Find out from experts and practitioners how social prescribing can help make pharmaceutical use more sustainable.

To reduce the impact of pharmaceutical pollution, one leverage point is to include the environmental impact of pharmaceuticals in healthcare decision-making. Read the full report to find out how…

Medicines like aspirin, anti-depressants and blood pressure drugs, are being used more and more by people. But more medicines for us means more medicines ending up in our rivers and seas, creating a dangerous cocktail for fish, wildlife and humans.

Co-Director Kelly Thornber explains how we apply a systems thinking approach to solve the challenge presented by pharmaceutical pollution.

Academics from across the University of Exeter have joined forces with thought leaders from other universities, industry, government and non-profit organisations, to call for societal-wide action on reducing pharmaceutical pollution from human healthcare.